Bariata, Pedro A.
HRN: 23-35-09 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/15/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
07/15/2023
07/21/2023
IV
1.5gram
Q6hr
Non-healing Wound, Both Feer; DM TYPE II UNCONTROLLED
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes